Cytotoxicity of natural extract from Tegillarca granosa on ovarian cancer cells is mediated by multiple molecules

Clinical and Investigative Medicine

Volumn 32, Issue 5, 2009, Pages

  Gao, Ming Qing ^a,b   Han, Yan Tao ^b   Li, Zhu ^b   Chen, Shou Guo ^c   Hong, Zhen Yu ^a   Wang, Chun Bo ^b  

^a Yonsei University College of Medicine   (South Korea)

^b QINGDAO UNIVERSITY   (China)

^c Qinggao Haili Biological Engineering Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CASPASE 3; CD24 ANTIGEN; HAISHENGSU; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CYTOTOXICITY; DRUG MECHANISM; GROWTH INHIBITION; MARINE SPECIES; OVARY CANCER; PRIORITY JOURNAL; TEGILLARCA GRANOSA;

ANIMALS; ANTIGENS, CD24; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARCIDAE; BETA CATENIN; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70350238393     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. American Cancer Society. Cancer Facts & Figures 2008. Atlanta: American Cancer Society; 2008.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. Adrian TE. Novel marine-derived anti-cancer agents. Curr Pharm Des 2007;13:3417-3426
4. Laport MS, Santos OC, Muricy G. Marine sponges: potential sources of new antimicrobial drugs. Curr Pharm Biotechnol 2009;10:86-105.
5. Jung WK, Jo HY, Qian ZJ, et al. A novel anticoagulant protein with high affinity to blood coagulation factor Va from Tegillarca granosa. J Biochem Mol Biol 2007;40:832-838
6. Li GY, Liu JZ, Yu XM, et al. Effect of a seashell protein Haishengsu on cell growth and expression of apoptosis genes in leukemia K562 cells. Clin Invest Med 2008;31:E218-21.
7. Yao RY, Chu X, Zhang YJ, Yang X, Liu XR, Wang CB. Anti-tumor effect of Haishengsu extracted from Tegillarca granosa inviter and in vivo. Chin J Mar Drugs 2005;24:33-36
8. Zhang CX, Li GY, Han CS, et al. Extract of Tegillarca granosa-Haishengsu in the treatment of advanced nonsmall cell lung cancer and advanced renal cell carcinoma. Chin J Mar Drugs 2005;24:55-58
9. Sharma A, Belna J, Logan J, Espat J, Hurteau JA. The effects of Omega-3 fatty acids on growth regulation of epithelial ovarian cancer cell lines. Gynecol Oncol 2005;99:58-64. (Pubitemid 41354583)
10. Chesire DR, Isaacs WB. Beta-catenin signaling in prostate cancer: an early perspective. Endocr Relat Cancer 2003;10:537-560 (Pubitemid 38094890)
11. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009;28:151-166
12. Peng B, Chang Q, Wang L, et al. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis. Gynecol Oncol 2008;108:173-181 (Pubitemid 350299442)
13. May P, May E. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 1999;18:7621-7636 (Pubitemid 30052689)
14. Al-Ayyoubi S, Gali-Muhtasib H. Differential apoptosis by gallotannin in human colon cancer cells with distinct p53 status. Mol Carcinog 2007;46:176-186 (Pubitemid 46399516)
15. Radhakrishna Pillai G, Srivastava AS, Hassanein TI, Chauhan DP, Carrier E. Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 2004;208:163-170 (Pubitemid 38624157)
16. Shiozaki H, Tahara H, Oka H, et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 1991;139:17-23.
17. Fujioka T, Takebayashi Y, Kihana T, et al. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Oncol Rep 2001;8:249-255 (Pubitemid 33758073)
18. Auzenne E, Ghosh SC, Khodadadian M, et al. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts. Neoplasia 2007;9:479-486 (Pubitemid 46983450)
19. Kristiansen G, Winzer KJ, Mayordomo E, et al. CD24 expression is a new prognostic marker in breast cancer. Clin Cancer Res 2003;9:4906-4913 (Pubitemid 37323297)
20. Saegusa M, Machida D, Hashimura M, Okayasu I. CD44 expression in benign, premalignant, and malignant ovarian neoplasms: relation to tumour development and progression. J Pathol 1999;189:326-337 (Pubitemid 29489216)
21. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumori-genic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-3988 (Pubitemid 36418143)
22. Li C, Heidt DG, Dalerba P, et al. Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037 (Pubitemid 46270758)
23. Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008;68:4311-4320